Literature DB >> 11371819

Early failure of Pavlik harness treatment for developmental hip dysplasia: clinical and ultrasound predictors.

J A Lerman1, J B Emans, M B Millis, J Share, D Zurakowski, J R Kasser.   

Abstract

A cohort of 93 patients with developmental dysplasia of the hip (DDH) treated with a Pavlik harness were evaluated to determine predictors of treatment failure. Failure was defined as failure to achieve or maintain hip reduction in the Pavlik harness. Of 93 patients (137 hips), 17 (26 hips) failed Pavlik harness treatment. Univariate risk factors for failure included bilaterality, initial clinical exam, and initial ultrasound (US) percent coverage. Clinical exam and initial percent coverage were multivariate risk factors for failure. Among initially clinically dislocatable hips, a low initial US alpha angle correlated with an increased likelihood of failure. All (6/6) patients with an initially irreducible hip and an initial coverage of <20% by US eventually failed treatment. Gender, side of pathology, and age at diagnosis and initiation of treatment did not correlate with failure. Irreducibility by physical exam combined with US coverage of <20% identified a patient group that uniformly failed Pavlik harness treatment. These patients may be candidates for alternative bracing, traction, or closed or open reduction.

Entities:  

Mesh:

Year:  2001        PMID: 11371819

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  24 in total

1.  Success of Pavlik Harness Treatment Decreases in Patients ≥ 4 Months and in Ultrasonographically Dislocated Hips in Developmental Dysplasia of the Hip.

Authors:  Hakan Ömeroğlu; Nusret Köse; Anil Akceylan
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  What Risk Factors and Characteristics Are Associated With Late-presenting Dislocations of the Hip in Infants?

Authors:  Kishore Mulpuri; Emily K Schaeffer; Janice Andrade; Wudbhav N Sankar; Nicole Williams; Travis H Matheney; Scott J Mubarak; Peter J Cundy; Charles T Price
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

3.  Indicators of successful use of the Pavlik harness in infants with developmental dysplasia of the hip.

Authors:  H Atalar; U Sayli; O Y Yavuz; I Uraş; H Dogruel
Journal:  Int Orthop       Date:  2006-04-07       Impact factor: 3.075

4.  The pubo-femoral distance decreases with Pavlik harness treatment for developmental dysplasia of the hip in newborns.

Authors:  Daniel Augusto Maranho; Felipe Nunes Donati; Vitor Faeda Dalto; Marcello Henrique Nogueira-Barbosa
Journal:  Skeletal Radiol       Date:  2017-05-24       Impact factor: 2.199

5.  Reduction of the dislocated hips with the Tübingen hip flexion splint in infants.

Authors:  Murat Yegen; Hakan Atalar; Cuneyd Gunay; Osman Yuksel Yavuz; Ismail Uras; Ahmet Yigit Kaptan
Journal:  Int Orthop       Date:  2018-11-27       Impact factor: 3.075

6.  Developmental dysplasia of the hip in the newborn: A systematic review.

Authors:  Vivek Gulati; Kelechi Eseonu; Junaid Sayani; Nizar Ismail; Chika Uzoigwe; Muhammed Zaki Choudhury; Pooja Gulati; Adeel Aqil; Saket Tibrewal
Journal:  World J Orthop       Date:  2013-04-18

7.  Higher Pavlik Harness Treatment Failure Is Seen in Graf Type IV Ortolani-positive Hips in Males.

Authors:  Eduardo N Novais; Lauryn A Kestel; Patrick M Carry; Mariana L Meyers
Journal:  Clin Orthop Relat Res       Date:  2016-03-14       Impact factor: 4.176

8.  Instability of the neonatal hip: the role of early or late splintage.

Authors:  R W Paton; P J Hopgood; K Eccles
Journal:  Int Orthop       Date:  2004-08-12       Impact factor: 3.075

9.  Anterior axial ultrasound in monitoring infants with Pavlik harness.

Authors:  Julie El Ferzli; Saad Abuamara; Danielle Eurin; Patrick Le Dosseur; Jean-Nicolas Dacher
Journal:  Eur Radiol       Date:  2003-06-12       Impact factor: 5.315

10.  Pseudoparalysis in the Pavlik Harness: beware of septic arthritis.

Authors:  Andrew J Stevenson; Sandeep B Shewalle; Nicholas M P Clarke
Journal:  J Child Orthop       Date:  2007-10-13       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.